A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy
Introduction NK cells mediate potent anti-tumor activity without prior exposure to specific antigens.1–3 They attack tumors in an MHC-independent manner, clearing cancer cells that antigen-specific T cells cannot target.4 However, enhancing NK cell …